DE3478230D1 - Cloning and expression vectors for gamma interferon, transformed bacterias and process for the preparation of gamma-interferon - Google Patents

Cloning and expression vectors for gamma interferon, transformed bacterias and process for the preparation of gamma-interferon

Info

Publication number
DE3478230D1
DE3478230D1 DE8484402502T DE3478230T DE3478230D1 DE 3478230 D1 DE3478230 D1 DE 3478230D1 DE 8484402502 T DE8484402502 T DE 8484402502T DE 3478230 T DE3478230 T DE 3478230T DE 3478230 D1 DE3478230 D1 DE 3478230D1
Authority
DE
Germany
Prior art keywords
interferon
gamma
cloning
preparation
expression vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484402502T
Other languages
German (de)
English (en)
Inventor
Paul Sondermeyer
Michael Courtney
Luc-Henri Tessier
Jean Pierre Lecocq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Application granted granted Critical
Publication of DE3478230D1 publication Critical patent/DE3478230D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE8484402502T 1983-12-09 1984-12-05 Cloning and expression vectors for gamma interferon, transformed bacterias and process for the preparation of gamma-interferon Expired DE3478230D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8319777A FR2556365B1 (fr) 1983-12-09 1983-12-09 Vecteurs de clonage et d'expression de l'interferon-g, bacteries transformees et procede de preparation de l'interferon-g

Publications (1)

Publication Number Publication Date
DE3478230D1 true DE3478230D1 (en) 1989-06-22

Family

ID=9295048

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484402502T Expired DE3478230D1 (en) 1983-12-09 1984-12-05 Cloning and expression vectors for gamma interferon, transformed bacterias and process for the preparation of gamma-interferon

Country Status (8)

Country Link
US (1) US5081022A (fr)
EP (1) EP0146462B1 (fr)
JP (1) JPS61500588A (fr)
AT (1) ATE43139T1 (fr)
CA (1) CA1245584A (fr)
DE (1) DE3478230D1 (fr)
FR (1) FR2556365B1 (fr)
WO (1) WO1985002624A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
FR2598430B1 (fr) * 1986-05-06 1990-02-02 Roussel Uclaf Nouveaux vecteurs d'expression, leur procede d'obtention et leur application pour exprimer une proteine quelconque dans escherichia coli
DK408687A (da) * 1986-08-05 1988-02-06 Transgene Sa Fremgangsmaade til stabilisering af et plasmid
JPH07163368A (ja) * 1993-12-15 1995-06-27 Hayashibara Biochem Lab Inc 組換えｄｎａとその組換えｄｎａを含む形質転換体
NZ527590A (en) 2001-03-09 2005-12-23 Genentech Inc Process for production of polypeptides
AU2008201682B2 (en) * 2004-02-02 2011-02-24 Ambrx, Inc. Modified human interferon polypeptides and their uses
GB2429207A (en) 2004-02-02 2007-02-21 Ambrx Inc Modified human interferon polypeptides and their uses
US8097161B2 (en) * 2006-09-21 2012-01-17 Asahi Kasei Chemicals Corporation Wastewater treatment method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO811119L (no) * 1980-06-06 1981-12-07 Biogen Nv Forbedrede baerere, samt fremgangsmaate ved fremstilling av disse og for aa uttrykke klonede gener
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
IL68100A0 (en) * 1982-03-24 1983-06-15 Takeda Chemical Industries Ltd Novel dna and use thereof
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
FR2526661B1 (fr) * 1982-05-13 1986-02-21 Transgene Sa Nouveaux vecteurs d'expression de la proteine antigenique de la rage et leur application a la preparation de vaccins
JPH0787797B2 (ja) * 1982-05-20 1995-09-27 サントリー株式会社 ヒト・ガンマ・インタ−フエロン様ポリペプチドの製造法
US4582800A (en) * 1982-07-12 1986-04-15 Hoffmann-La Roche Inc. Novel vectors and method for controlling interferon expression
WO1984002129A1 (fr) * 1982-11-22 1984-06-07 Takeda Chemical Industries Ltd Proteine de l'interferon immun humain et son procede de preparation
US4578355A (en) * 1983-01-12 1986-03-25 The United States Of America As Represented By The Department Of Health And Human Services Plasmid cloning vector pAS1

Also Published As

Publication number Publication date
FR2556365A1 (fr) 1985-06-14
EP0146462B1 (fr) 1989-05-17
EP0146462A2 (fr) 1985-06-26
US5081022A (en) 1992-01-14
FR2556365B1 (fr) 1987-07-31
JPS61500588A (ja) 1986-04-03
WO1985002624A1 (fr) 1985-06-20
ATE43139T1 (de) 1989-06-15
CA1245584A (fr) 1988-11-29
EP0146462A3 (en) 1985-08-14

Similar Documents

Publication Publication Date Title
EG19101A (en) Process for preparing of expression of human proapolipoprotein A.1.
ES8202588A1 (es) Un procedimiento para la preparacion de una proteina quimera
IL68790A (en) Polydeoxyribonucleotide coding for ifn-alpha2(arg),plasmid containing it,cloning of said plasmid and microorganisms containing it and ifn-alpha(arg)encoded by said polydeoxyribonucleotide and its preparation
DE3379959D1 (en) Process for the preparation of interferon and expression vehicles therefor
FR2681786B1 (fr)
ES8607388A1 (es) Un metodo para preparar que tiene sustancialmente la misma secuencia de aminoacidos que la superoxido-dismutasa humana.
UA13380A (uk) Спосіб одержаhhя лейкоцитарhого іhтерфероhу
EP0090505A3 (en) Human antithrombin iii, dna sequences therefor, expression vehicles and cloning vectors containing such sequences and cell cultures transformed thereby, a process for expressing human antithrombin iii, and pharmaceutical compositions comprising it
ES8207514A1 (es) Un procedimiento para la preparacion de interferon
DE3479321D1 (en) Biosynthetically produced human nerve growth factor, process for producing it, compositions containing it, dna sequence encoding it, vectors containing the sequence and host cells transformed thereby
DE3478230D1 (en) Cloning and expression vectors for gamma interferon, transformed bacterias and process for the preparation of gamma-interferon
ES8300857A1 (es) Un procedimiento para la sintesis de insulina humana
AU4444389A (en) Process for the expression of a recombinant gene
NZ241829A (en) Oxalate oxidase, genes encoding it, vectors and transformed plants
NZ334568A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
DE3479745D1 (en) Plasmid cloning and expression vectors for a protein in a microorganism, comprising at least the expression promotor of beta-glucosidase in the yeasts; these vectors containing microorganisms; fermentation process and enzymes so obtained
AU575331B2 (en) Improved e. coli plasmid containing modified 5' cipoprotein sequence
EP0422217A4 (en) Human recombinant placental ribonuclease inhibitor and method of production
HUT75734A (en) Expression of heterologous proteins in attenuated bacteria using the htra-promoters
UA19039A (uk) Спосіб одержаhhя еритропоетиhу людиhи
SU1380209A1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee